Sulphonylureas Glimeperide: doses of 2-4mg a day have a peripheral GLUT-4 activity reducing insulin requirement by 10-20%
According to Medd, When used alongside retinoids, it can help mitigate potential dryness and irritation while boosting the overall anti-ageing benefits
PPARs and the cardiovascular system
View source K Koike, Y Yamamoto, N Suzuki, R Yamazaki, C Yoshikawa, F Takano, et al
Phase 1 Trials In a first-in-human, randomized, placebo-controlled, single ascending dose, phase 1 trial in healthy participants, retatrutide demonstrated a favourable safety profile (similar to other incretin-based therapies) and early signs of efficacy with dose-dependent WL [42]